Intra-Cellular Therapies Operating Expenses 2013-2024 | ITCI

Intra-Cellular Therapies operating expenses for the twelve months ending September 30, 2024 were $0.735B, a 24.04% increase year-over-year.

  • Intra-Cellular Therapies annual operating expenses for 2023 were $0.624B, a 21.37% increase from 2022.
  • Intra-Cellular Therapies annual operating expenses for 2022 were $0.514B, a 39.09% increase from 2021.
  • Intra-Cellular Therapies annual operating expenses for 2021 were $0.369B, a 45.45% increase from 2020.

Intra-Cellular Therapies Operating Expenses 2013-2024 | ITCI

  • Intra-Cellular Therapies annual operating expenses for 2023 were $0.624B, a 21.37% increase from 2022.
  • Intra-Cellular Therapies annual operating expenses for 2022 were $0.514B, a 39.09% increase from 2021.
  • Intra-Cellular Therapies annual operating expenses for 2021 were $0.369B, a 45.45% increase from 2020.